Search Results

Displaying Results 1826-1850 of 20576 "'R'"

Aug 14, 2026, 16:30 ET Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

$1.0 million for the three months ended June 30, 2026, and $5.5 million for the nine months ended June 30, 2026;Research and development (R&D) expenses of $0.2 million for the three months ended June 30, 2026, compared to $0.9 million for the prior-year quarter; and $2.3 million for the nine

More news about: Citius Oncology, Inc.


Aug 14, 2026, 16:01 ET A1R water Debuts as Publicly Traded Company to Build Leading CPG Brand in Atmospheric Water

IPXG). AdvisorsMorgan, Lewis & Bockius LLP served as legal counsel to A1R water, Ogier (Cayman) LLP served as Cayman Islands counsel to A1R water, Jett Capital Advisors served as financial advisor and PIPE placement agent to A1R water, White & Case LLP served as legal counsel to Inflection Point,

More news about: Air Water Ventures Holdings Ltd.


Aug 14, 2026, 16:01 ET FiEE, Inc. Announces Second Quarter and First Half 2026 Unaudited Financial Results

operations of the Company, (ii) our ability to successfully implement our strategic business transformation, (iii) our commitment to investing in R&D and our ability to execute on our AI music and home entertainment initiatives, including our expectations regarding streaming revenue, creator royalties,

More news about: FiEE, Inc.


Aug 14, 2026, 16:00 ET BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

placebo-controlled portion (Part A), then an open-label extension in which all participants receive NurOwn (Part B). The primary endpoint is change on the ALSFRS-R scale, and Part A results are intended to support a new BLA. ENDURANCE will be conducted under a Special Protocol Assessment with the FDA, the first ever

More news about: BrainStorm Cell Therapeutics Inc.


Aug 14, 2026, 15:20 ET PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz announces that investors with losses related to PROCEPT BioRobotics Corporation (PRCT) have opportunity to lead the securities fraud

More news about: The Law Offices of Frank R. Cruz, Los Angeles


Aug 14, 2026, 13:52 ET DeFi Technologies Inc. gibt die Finanzergebnisse für das zweite Quartal 2026 bekannt: Umsatz von 7,8 Mio. USD, operativer Verlust von 2,3 Mio. USD und weiterhin solide Bilanz

14. August 2026 /PRNewswire/ -- DeFi Technologies Inc. (das „Unternehmen" oder „DeFi Technologies") (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B) (B3: DEFT31), ein Fintech-Unternehmen, das die Lücke zwischen traditionellen Kapitalmärkten und dezentraler Finanzwirtschaft („DeFi") schließt, hat

More news about: DeFi Technologies Inc.


Aug 14, 2026, 13:03 ET Rockford Fosgate® Introduces PMX-6BB Hidden Digital Media Receiver for Seamless Marine Audio Control

tailored to create the ideal audio experience without affecting the other.For greater system flexibility, the PMX-6BB supports up to three PMX-1R remotes and a PMX-8DH TFT display head, providing multiple control options throughout the vessel. Independent subwoofer level control also allows users

More news about: Rockford Fosgate


Aug 14, 2026, 12:22 ET Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II

https://news.cision.com/photocure/r/photocure-welcomes-fda-proposal-to-initiate-the-reclassification-of-blue-light-cystoscopy-systems-fr,c4383747The following files are available for download:

More news about: Photocure


Aug 14, 2026, 12:18 ET Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II

https://news.cision.com/photocure/r/photocure-welcomes-fda-proposal-to-initiate-the-reclassification-of-blue-light-cystoscopy-systems-fr,c4383747The following files are available for download:

More news about: Photocure


Aug 14, 2026, 12:00 ET Wix.com Ltd. (WIX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz announces that investors with losses related to Wix.com Ltd. (WIX) have opportunity to lead the securities fraud class action lawsuit.

More news about: The Law Offices of Frank R. Cruz, Los Angeles


Aug 14, 2026, 11:46 ET /C O R R E C T I O N -- GA Telesis, LLC/

More news about: GA Telesis, LLC


Aug 14, 2026, 11:44 ET Aurisco Pharmaceutical est le premier fabricant mondial d'oligonucléotides génériques à avoir passé avec succès l'inspection de l'USFDA

propos d'Aurisco Aurisco Pharmaceutical Co., Ltd. (SSE : 605116) est présent sur les marchés internationaux depuis 1998. Avec 6 centres de R&D, 4 sites de production et des bureaux commerciaux aux États-Unis, au Portugal, en Inde et au Brésil, l'entreprise se consacre à la fabrication de produits

More news about: Aurisco Pharmaceutical


Aug 14, 2026, 11:00 ET Novogradac to Celebrate Affordable Housing Achievements at Upcoming Conference

2026 Housing Tax Credit and Bonds Conference is co-hosted by Huntington Bank. Enterprise Community Partners/BWE, Lument, Polsinelli Law Firm, PNC Bank, R4 Capital and Sugar Creek Capital are sponsoring the conference. Exhibitors include Boston Capital Finance LLC and Scott Insurance.Novogradac will

More news about: Novogradac & Company LLP


Aug 14, 2026, 10:30 ET Dodge Follows Roadkill Nights Kickoff with Woodward Dream Cruise Display

600-horsepower Charger Super Bee, Durango R/T Smokescreen Concept and New Red Oxide Exterior Charger Color to Be HighlightedDodge drops Charger's new Red Oxide exterior

More news about: Stellantis


Aug 14, 2026, 09:10 ET Insilico Medicine Introduces Biological Age into Virtual Cell Research: Launches Virtual Aging Cell Webpage and Previews Multi-Agent Driven VAC Generation Platform

to predict biological age and distinguish disease from control samples. Using this model, the team identified dual-purpose targets such as APLNR and IL23R, with both anti-aging and anti-age-related-disease potential. The results were published in

More news about: Insilico Medicine


Aug 14, 2026, 09:04 ET Category Disruptor Living Proof Debuts Sheer Clean Dry Shampoo Mist, its First Non-Aerosol Dry Shampoo Inspired by Skincare

exploring more than 30 pump options — we refined the formula to deliver a consistent, high-performing clean hair experience." said Ron McLaughlin, Chief R&D Officer at Living Proof.To power this category-defining innovation, the Living Proof scientists looked beyond traditional haircare and drew

More news about: Living Proof


Aug 14, 2026, 09:00 ET Vanova Health Enables Independent Physicians to Capture the Full Value of Care Delivered With Arintra's Autonomous Medical Coding

100 in the 2026 KLAS Emerging Company Spotlight report, and customers like Mercyhealth have achieved a 5.1% revenue uplift and 60% reduction in pre-A/R days after implementing Arintra across ten specialties. Arintra will exhibit at

More news about: Arintra


Aug 14, 2026, 09:00 ET K-Trot Campaign in New York's Times Square Draws Attention in Celebration of Korea's 81st Liberation Day

luxury tuxedo brand in Cheongdam-dong, Seoul. The photobook will be provided as a commemorative gift to VIP guests and sold in limited quantities to R- and S-seat ticket holders.Official sponsors Egg Cosmetic, which operates the global K-Beauty brand houry, and Korea Agriculture Corporation, which

More news about: NOM.NOM.NOM SHOW


Aug 14, 2026, 09:00 ET Greenland Technologies Reports Strong Second Quarter and First Half 2026 Financial Results

stock-based compensation expense. Research and development expenses increased 135.9% to $1.05 million from $0.44 million, primarily due to increased R&D activities.Income from operations was $5.98 million, compared with an operating loss of $2.32 million in the prior-year period.Net

More news about: Greenland Technologies Holding Corporation


Aug 14, 2026, 08:30 ET Sleep as a Window into Early Stages of Alzheimer's Pathophysiology: Implications for Clinical Development, Upcoming Webinar Hosted by Xtalks

design.Join experts Jacobo E. Mintzer, MD, MBA, Distinguished Fellow, American Psychiatric Association; Professor, Medical University of South Carolina; Joseph R. Winer, PhD, Neuroscientist, California Pacific Medical Center Research Institute, San Francisco Coordinating Center, UCSF; and Jay Pathmanathan, MD,

More news about: Xtalks


Aug 14, 2026, 08:00 ET SK bioscience Advances Development of Next-Generation Infectious Disease Prevention Platform with Global Phase 1b CTA Submission for RSV Preventive Antibody Candidate

combining it with our own R&D capabilities represents a meaningful milestone. We will continue to strengthen our ability to respond to global infectious disease threats by securing and advancing diverse prevention platforms."SK bioscience continues to expand its global R&D network through collaborations

More news about: SK bioscience


Aug 14, 2026, 07:52 ET Fractal's Vaidya.ai Powers BMC Health AI Chatbot on WhatsApp for Mumbai

by embedding AI into critical decisions across business functions and industry verticals.Fractal invests more than 6% of its revenue in AI R&D, supporting foundational AI research, product development, and IP creation that address both immediate client needs and long-term technological advancement.

More news about: Fractal Analytics Limited


Aug 14, 2026, 07:45 ET TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

2026: Expect to initiate Phase 1b/2 trial of VISTA in mutNPM1 r/r AML2H 2026: Expect to receive orphan drug designation in AML1H 2027: Expect preliminary safety and response data for VISTA in mutated NMP1 r/r AMLMDSC Inhibitors (Bi-specific ADCs)

More news about: TuHURA Biosciences, Inc.


Aug 14, 2026, 07:01 ET Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update

approximately $2.5 million of gross proceeds through a Registered Direct Offering, as well as $0.8 million under the Equity Line of Credit.R&D Expenses:Research and development expenses for the three months ended June 30, 2026 were $1.1 million compared to $0.5 million for the three

More news about: Acurx Pharmaceuticals, Inc.


Aug 14, 2026, 07:00 ET OLD REPUBLIC DECLARES THIRD QUARTER REGULAR DIVIDEND OF 31.5 CENTS PER SHARE

Financial Relations Board:Craig R. Smiddy: President and Chief Executive OfficerInvestors:

More news about: Old Republic International Corporation


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.